TMPRSS2 and prostate carcinoma: In prostate cancer, TMPRSS2 activated pro-hepatocyte growth factor (HGF) and then promoted c-MET receptor tyrosine kinase signaling to regulate cell carcinogenesis (Lucas et al., 2014).